Aydın Karahan

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Mark S. Anderson, P. Gregersen, R. Nussbaum, 2021, Science Immunology.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopolysaccharide-induced sepsis.

L. Tamer, M. Dirlik, A. Polat, 2009, Current therapeutic research, clinical and experimental.

Determination of Risk Factors in the Development and Prevalence of Pressure Sores in Patients Hospitalized in a Cardiovascular and Thoracic Surgery Intensive Care Unit

Tülin Akarsu Ayazoğlu, Didem Onk, Yavuz Gun, 2018, Eurasian Journal of Medical Investigation.